Federal prime contract award
Recipient: ELUSYS THERAPEUTICS INC
Awarding agency: Department of Health and Human Services — Office of Assistant Secretary for Preparedness and Response
Description: ANTHIM (OBILTOXAXIMAB)
Award type: DEFINITIVE CONTRACT
Award amount: $124523123.01
Total outlays: $73026248
Period of performance: 2024-05-01 to 2028-12-31
NAICS: 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING
PSC: 6505 — DRUGS AND BIOLOGICALS
Place of performance (state): NJ